Hib Vaccine Lawsuit
Our lawyers are evaluating lawsuits for children who were diagnosed with a Shoulder Injury Related to Vaccine Administration (SIRVA) after receiving a vaccination against Hib disease.
Overview
Hib vaccines are immunizations that are given with a needle. They protect children against infections with the bacteria Haemophilus influenzae type B.
List of Hib Vaccines
- ActHIB®
- Hiberix®
- MenHibrix®
- PedvaxHib®
- Pentacel®
- Comvax®
- And more
How is Hib Vaccine Given?
Hib vaccines are given as a 0.5-mL injection that is administered into the thigh muscle for infants, or the upper arm for older children.
Can Hib Vaccine Cause SIRVA?
Hib vaccines that are injected into the deltoid muscle of the upper arm can potentially caused an inflammatory reaction in the shoulder, called a Shoulder Injury Related to Vaccine Administration (SIRVA). It usually occurs when the needle is improperly injected too high or too deep in the shoulder.
Symptoms of SIRVA After Hib Vaccines
- Arm pain
- Shoulder pain
- Intense, stabbing pain
- Shoulder dysfunction
- Limited range of motion
- Lack of flexibility
- Inflammation
Hib Vaccine Lawsuits
If your child was diagnosed with a serious shoulder injury from a Hib vaccine, our lawyers may be able to help you seek up to $250,000 in financial compensation from the Vaccine Injury Compensation Program (VICP).
What is the VICP?
The VICP is a program that provides financial compensation to people who inevitably suffer the rare but serious side effects of vaccines. The program was established in the 1980s to protect pharmaceutical companies against individual lawsuits from people who were injured.
Over $70 Million Paid in SIRVA Lawsuits Since 2011
On average, SIRVA lawsuits are paid $140,000 per person, but the payout can be a maximum of $250,000. Every year, the VICP pays out millions of dollars to hundreds of people who are inevitably injured by vaccine side effects. For example, since 2011, around $70 million was paid to 500 people who developed severe shoulder injuries (SIRVA).
